What are the Clinical Applications of ADCC in Cancer Therapy?
ADCC is leveraged in various clinical settings to improve cancer treatment outcomes. Monoclonal antibodies that induce ADCC are used not only in hematologic malignancies but also in solid tumors. Combination therapies, where mAbs are used alongside chemotherapeutic agents or immune checkpoint inhibitors, are being explored to potentiate the anti-tumor response. Clinical trials continue to investigate new mAbs and combination regimens to expand the applicability and effectiveness of ADCC in cancer therapy.
